Table 2 Clinical presentation of study groups
Clinical presentation | HIV/HTLV-1, n(%) (n = 29) | HIV, n(%) (n = 59) | p value* |
|---|---|---|---|
Assymptomatic | 7 (24.1) | 14 (23.7) | Â |
Papular pruritic eruptions | 3 (10.3) | 14 (23.7) | Â |
Dermatitis | 2 (6.9) | 2 (3.4) | Â |
Seborrhoeic dermatitis | 2 (6.9) | 0 (0.0) | Â |
Folliculitis | 0 (0.0) | 1 (1.7) | Â |
Herpes zoster < 5 years | 3 (10.3) | 4 (6.8) | 0.570 |
TInea capitis | 5 (17.2) | 8 (13.6) | Â |
Candidiasis | 3 (10.3) | 4 (6.8) | Â |
Tuberculosis < 1 year | 1 (3.5) | 4 (6.8) | Â |
Weight loss > 10% | 3 (10.3) | 7 (11.9) | Â |
Chronic diarrhoea | 0 (0.0) | 1 (1.7) | Â |